VivoSeq
Other

Colonization

0

Pipeline Programs↗

11

Active Trials↗

3

Companies Involved↗

Colonization is an early-stage landscape with 0 programs across 3 companies. The most active players are Locus Biosciences, Pfizer, NovaDigm Therapeutics, Inc..

Intelligence

Pipeline Metrics

Competitive Density

28/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

77/100

Attrition Rate

16/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

L

Locus Biosciences

0 programs

PreclinicalPfizer logo

Pfizer

0 programs

PreclinicalN

NovaDigm Therapeutics, Inc.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

50

clinical trials

Completed27 · 54%
Recruiting9 · 18%
Terminated7 · 14%
Unknown status4 · 8%
Withdrawn1 · 2%
Not yet recruiting1 · 2%
Other1 · 2%

Clinical Trials

Trial Activity

50 trials

Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP
Recruiting·UUniversity of Virginia·Phase 4·NCT05094570·20 enrolled
Decolonization of Gram-negative Multi-resistant Organisms (MDRO) with Donor Microbiota (FMT)
Recruiting·UUniversity Hospital, Ghent·Phase 2/3·NCT04188743·150 enrolled
Antimicrobial Prophylaxis for Skin Colonization With Propionibacterium Acnes in Primary Open Shoulder Surgery
Recruiting·UUniversité de Montréal·N/A·NCT02996656·88 enrolled
Optimization of Skin Preparation to Reduce Cutibacterium Acnes Colonization in Superficial and Deep Samples During Prosthetic Shoulder Surgery in Male Patients
Recruiting·NNantes University Hospital·Phase 3·NCT04028401·110 enrolled
PMT for MDRO Decolonization
Recruiting·UUniversity of Pennsylvania·Phase 2·NCT05632315·150 enrolled
Bacterial Decolonization Within Dyads
Recruiting·—·N/A·NCT06541145·20 enrolled
MRSA Decolonization in Complicated Carriage
Recruiting·LLeiden University Medical Center·N/A·NCT05268120·211 enrolled
FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae
Recruiting·FFondazione Policlinico Universitario Agostino Gemelli IRCCS·Phase 1/2·NCT04759001·52 enrolled
FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae
Recruiting·FFondazione Policlinico Universitario Agostino Gemelli IRCCS·Phase 1/2·NCT05791396·36 enrolled
The Efficacy of Probiotics to Reduce Antepartum Group B Streptococcus Colonization.
Active, not recruiting·MMarquette University·Phase 2·NCT03696953·109 enrolled
Xylitol Use for Decolonization of C. Difficile in Patients With IBD
Not yet recruiting·—·Phase 1·NCT05852587·99 enrolled
The Natural History of Community-Associated MRSA Infections and Decolonization Strategies
Completed·WWashington University School of Medicine·N/A·NCT00513799·300 enrolled
Gastric Acid Suppression and Probiotic Colonization
Completed·SStanford University·Phase 4·NCT03327051·39 enrolled
Prevention of GBS Colonization Via Immunity
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT00128219·667 enrolled
Safety, Tolerability, and PK of LBP-EC01 in Patients With Lower Urinary Tract Colonization Caused by E. Coli
Completed·LLocus Biosciences·Phase 1·NCT04191148·36 enrolled
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)